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Abstract

Synthesis of Pyranobenzopyrans

Sumiea B. Eltayeb
Doctor of Philosophy in Chemistry
Seton Hall University Dr. Cecilia H. Marzabadi, Advisor

Carbohydrates and their derivatives are involved in a wide array of
biological processes and are crucial for the survival of living entities. As a result,
sugar-based compounds have become attractive scaffolds for drug design. In
addition, pyranobenzopyran derivatives have shown promise in the treatment of
numerous health conditions such as

anticoagulants, antifungal, and anti-

inflammatory agents. They have also shown important properties as antibiotics
anti-AIDS agents) and antitumor drugs.
The main point of our research was to determine and develop a synthetic
method for the preparation of pyranobenzopyrans and carbohydrate fused
heterocyclic compounds. This was accomplished via a [4+2] cycloaddition reaction
to generate the oxygen-containing six-membered ring by the addition of the imine
o-hydroxybenzaldimine and its derivatives to glucals in organic solvent under
catalysis by scandium triflate. The conventional method and microwave reactor
method were initially used to achieve this goal, but no reaction was observed.
The failure of these reactions may be due to the sugar protecting group such
as the acetyl ester. Acetyl could deactivate electronically, where benzyl and
x

butyldimethylsilyl ethers created steric hindrance and inhibited the reaction. Then
new methodology was developed and an ionic liquid was used as a solvent to
dissolve the D-glucal and the other reactants. A series of pyranobenzopyrans
have been prepared via Lewis Acid catalyzed cycloaddition reactions of D-glucal
and o-hydroxybenzaldehyde and its derivatives in room temperature imidazolium
ion-based ionic liquid solvents. Different o-hydroxybenzaldehyde derivatives were
tested to study the effect of the substituents in the rate of the reaction. Four
products were obtained in poor to moderate yields. Because 2-hydroxy-5nitrobenzaldehyde, 2-hydroxy-5-methylbenzaldehyde and 2,5-dihydroxybenzaldehyde
were insoluble in the ionic liquids, no product was obtained from their reaction
with D-glucal. Danishefsky’s Diene, 1-methoxy-3-trimethylsiloxy-1, 3-butadiene, was
also reacted in ionic liquid and the product 2-5,8a-dihydroxy-1(hydroxymethyl)1,4a, 5, 6, 7,8a-hexahydro-8H-isochromenone was obtained in moderate yield. In
these reactions, the glycal itself was found to serve as a diene with another
molecule of glycal as the dienophile to form an interesting sugar dimer.
All the structures prepared were confirmed by NMR and elemental analyses.
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Chapter 1

Introduction

1.1. Carbohydrates
1.1.1. General Structure and Properties of
carbohydrates
The term carbohydrates was originally derived in the nineteenth century from the
French term (hydrate de carbon) for the family of the compounds possessing the
empirical formula Cn (H2O)n.1 Carbohydrates are a unique family of poly functional
molecules; they exist as monosaccharide building blocks that are linked together
in almost limitless ways to form oligosaccharides and polysaccharides. 2
Monosaccharides are polyhydroxy -aldehydes or ketones. The most common types
of structures are aldoses (Figure 1.1) and consist of linear carbon chains with an
aldehyde (CHO ) group at C-1 and varying number of carbon atoms that are
secondary alcohols (CHOH), and a primary alcohol (CH2OH) at the terminal end.
Ketoses ( Figure 1.2) have a primary alcohol at both ends and have a ketone
carbonyl (C=O) within the chain at C-2.2

1

Figure 1.1. Aldoses General Structure.

Figure1. 2. Ketoses General Structure.

The simplest example of an aldose is glyceraldehyde that consists of three
carbons. Higher sugars containing four carbons are known as tetroses, five
carbons pentoses, and six carbons hexoses (Figure 1.3).
Figure 1.3 Example of Aldoses.

Glyceraldehyde

Tetrose

Pentose

Hexose

Figure 1.4. Example of Ketoses

Dihydroxyacetone

Ketotetrose

Ketopentose

Ketohexose

2

Each of the carbon atoms that are secondary alcohols have four different
groups attached and are stereogenic (or chiral) centers, giving rise to
stereoisomers. Although the stereoisomeric diversity is often times problematic and
the chemistry of carbohydrates present numerous challenges, their widespread
presence in biological systems makes them attractive targets for continued
research, especially in the field of therapeutics.3 In addition, carbohydrate
products are utilized in food, clothing, and the agrochemical industry.4 The
importance of carbohydrates to living things can hardly be overemphasized. The
energy stores of most animals and plants are both carbohydrate and lipid in
nature; carbohydrates are generally available as an immediate energy source,
Glucose, the prevalent uncombined, or free, sugar circulating in the blood of
higher animals, is essential to cell function. The proper regulation of glucose
metabolism is of paramount importance to survival.3
1.1.2 The Structure and Properties of Glucose.
The structure and properties of glucose will be considered in greater detail than
those of the other monosaccharides. Glucose is an aldohexose, which means
the structure has a six-carbon sugar with a terminal aldehyde group. From the
formula C6H12O6 sixteen possible configurational isomers are known- some occur
naturally and the others have been synthesized. This problem of identifying
glucose as a particular one of the sixteen possibilities was solved by Emil
Fischer during the latter part of the nineteenth century, and he was awarded the
Nobel Prize in chemistry in 1902.4 Fischer established the fundamental

3

groundwork that provides the basis of the structure of the enantiomer of natural
glucose shown in the projections of the formula 1 and formula 2.

1

2

The great difficulties of working with carbohydrates, are: their considerable
solubility in water, their instability to strong oxidizing agents and acidic or basic
reagents, their reluctance to crystallize, and their tendency to decompose rather
than give sharp melting points.4
1.1.3. Ring Structure of Monosaccharides
Any given mixture of an aldehyde and alcohol is in equilibrium with a hemiacetal,
a process which forms a new stereogenic center . Since carbohydrates have both
carbonyl and hydroxyl functions they are capable of forming intramolecular
hemiacetals, known as lactols.2 The cyclic form occurs because of a nucleophilic
addition reaction between the hydroxyl group of C-4 or C-5 and the carbonyl
functionality at C-1. Either hemi-acetals or hemi-ketals form, depending on the type of
sugar.
1.1.4. Six-Membered Cyclic Pyranoses and Five-Membered Cyclic Furanoses.
Pyranoses and furanoses forms are further subdivided on the basis of how they
4

cyclize. During the cyclization, the anomeric carbon
(the hemiacetal carbon atom originating from the carbonyl oxygen) becomes a
sterogenic center with two possible configuration α or β. (figure 1.5) depending
on the way they cyclize. The resulting isomers are called anomers and the
interconversion of the anomers in solution called mutarotation. Mutarotation is the
change in optical rotation that occurs by epimerization at the anomeric center.
That means, it is the change in the equilibrium between two anomers, when the
corresponding stereocenters interconvert. Cyclic sugars show mutarotation as α
and β anomeric forms interconvert. In aqueous solution, D-glucose exists as a
mixture of 38% α and 62% β (Figure 1.6). The β is favored because all of the
hydroxyl group are in equatorial position on the ring, while in α anomer, one
hydroxyl group is forced into the axial position which causes higher energy in
the molecule and makes it less stable.2

5

Figure 1.5. Configuration of the Hydroxyl Group at the Anomeric Carbon

Another equilibrium process that is characteristic of sugars is conformational
interconversion of the cyclic ring. where the six- membered ring can undergo an
equilibrium between different chair conformations. For glucopyranose, the 4C1
conformation is preferred because all the hydroxyl group substituents are in the
equatorial position while 1C4 conformation has all the hydroxyl groups in the
axial position.

6

Figure 1.6. Conformational Conversion of the Cyclic ring

4C
1

1C
4

1.1.5. The Biological Importance of Sugars.
Carbohydrates are one of most abundant biomolecules on the Earth and they
are involved in many essential biological processes: they act as an energy
source, in biological signaling and recognition mechanisms and as basic
structural building blocks controlling the architecture of nature. For example,
sugars are integral parts of DNA, RNA, starch, cellulose and chitin (insect and
lobster shells). D-glucose is central to several biochemical pathways. For example, it
is the major fuel of most organisms and occupies an essential position in both
anabolic and catabolic reactions. Glucose is the product of photosynthesis carried
out by plants whereby energy from sunlight is converted into chemical bonds
(Scheme 1).6
Light + 6H2O + 6CO2

C6H12O6 (glucose) + 6CO2

Glucose is a building unit for many disaccharides, for example sucrose
(commonly known as table sugar) consists of glucose and fructose. Starch is a
polymer of glucose units, consisting of a mixture of amylose (linear) and
amylopectin (branched), is used in plants for energy storage. It is found in the
7

tuber, roots, fruits and seeds of plants. Glycogen is a highly branched, high
molecular weight polymer of D-glucose that is the mammalian counterpart to
starch. It serves as an abundant energy storage form of carbohydrates, and
occurs widely in nature.2 Sugars can also play important roles in other biological
activities such as signals communication both within and between cells. 1 The
correct carbohydrate structures on cell surfaces are also necessary for the
fertilization of eggs by sperm and for development of embryos. 1Many
carbohydrates in the cell are covalently bound to proteins or lipids that are
coated on the surface of the cells where they act as recognition molecules for
viruses, and other pathogens.7
Complex carbohydrates are chains of monosaccharides, often called glycans.The
carbohydrates attached to proteins are known as glycoproteins, whereas the
ones conjugated to the lipids are glycolipids., Glycans are involved in a variety
of biological processes including protein folding and signaling events. Unlike
DNA and proteins, however, monosaccharides, may be linked to one or more
other monosaccharides, such that they form a branched tree structure.6
1.1.6. Carbohydrate-Based Drugs.
A relatively untapped source of new chemical entities of drugs comes from the
area of functional carbohydrates. All cell surfaces are coated with complex
carbohydrates which extend much further out from the cell than the protein
layer. These intricate molecules

act as recognition molecules, not just for other

cells, but also for pathogens that must identify and bind specific cell types for
successful infection. On the cell surface, they form layers known as glycocalyx

8

ranging from 10 to 100 nm in thickness and thus extending much further out
from the cell surface than proteins. 7
These O- and N-glycans are present in many different molecular forms including
glycoproteins, proteoglycans, glycolipids, and glycophosphatidylinositol-linked
proteins. Their broad diversity originates from their assembly from monosaccharide
building blocks, which can be linked with others at various positions on their
pyranose/furanose rings. In addition, branched structures are formed because
each ring can establish several linkages.8 Finally, the density of structural
information is further increased by the possibility of α- and β-isomers at the
anomeric center. These chemical characteristics bestow carbohydrates with optimal
properties that are desired for recognizing molecules. Certain proteins (called
lectins) have evolved three-dimensional domains (called carbohydrate-recognition
domains CRD) that can bind specific carbohydrate structures and thus decode
this information.8 Cell surface carbohydrates involved in specific cell- to- cell
recognition exhibit biological phenomena like cell adhesion, cell activation,
inflammatory migration, neurite outgrowth, and cancer metastasis. 1 Pathogens
including viruses, bacteria, and even parasites infect their host cells by
recognizing and binding to specific carbohydrates and cell surfaces, Perhaps the
most popular examples are the influenza viruses, which are designated by viral
coat proteins hemagglutinin (H) and neuraminidase (N).

Both of these viral

proteins, in fact, bind specific carbohydrate sequences on the host cell surfaces,
Antibodies that recognize carbohydrates and promote disease are identified as
therapeutic targets in autoimmune disease.9 “The identification of functional

9

carbohydrate epitopes and their corresponding specific carbohydrate-binding
proteins as new targets for drug development is emerging at a rapid rate due to
concerted worldwide efforts to organize and support technologies for elucidating
the human “glycome”.9 While carbohydrates act as excellent recognition
molecules on cell surfaces, many of their intrinsic properties make them poor
choices for small molecule drugs.10 In many cases the binding affinities of
monovalent carbohydrates are in the millimolar to micromolar range and are
therefore relatively weak and usually not adequate to complete with multivalent
interactions. The general hydrophilic nature of carbohydrates and their higher
density of hydroxyl groups work against the lipophilicity required for passive
absorption through the intestine.8
1.1.7. The Application and the Categories of Carbohydrate Drugs.
The pharmacokinetic properties of absorption, distribution, biotransformation and
excretion are important areas of focus in the field of drug discovery. This is,
especially true when dealing with sugar-based compounds.10 The ability to
generate structure activity relationship (SAR) data while balancing stability,
solubility, molecular weight, lipophilicity and metabolism is extremely important in
the “hit to lead” process, Although high throughput methodology and
combinatorial libraries hold many advantages for drug discovery, natural product
modification has the potential to provide improved structures for drug discovery
and to provide improved structural diversity. Often, sugar-based compounds have
enhanced activity against specific targets.3

10

A few dozen FDA-approved prescription drugs contain carbohydrate. Moieties as part
of their structures. These drugs can be divided into five categories, listed below:
1- Monosaccharide Conjugates.
2- Disaccharides and their Conjugates.
3- Trisaccharides and their Conjugates.
4- Oligosaccharides and Polysaccharides
5- Macrolides
1.1.7.1. Monosaccharide Conjugates
Monosaccharide Conjugates can be divided into four groups:.
1) Anthracycline antibiotics 26 and agents, 2) Nucleotides and nucleosides and
their analogs (for example an antitumor drug, 3) polyenes and the forth group of
monosaccharide drugs that contains a number of assorted compounds such as
Pentostatin 27, that inhibits RNA and DNA Synthesis by being a direct inhibitor of
enzymes adenosine deaminase and ribonucleotide reductase, particularly in cells
of the lymphoid system).12,13
Figure 1.7. Monosaccharide Conjugates

26
11

1.1.7.2. Disaccharides and their Conjugates.
The next subcategory of prescription carbohydrate drugs is disaccharides and
their conjugates. A good example of these is sucralfate 28, which is a β-Dfructofuranosyl-α-D-glucopyranoside basic aluminum sucrose sulfate complex. It
accelerates healing of duodenal ulcers, in part by inhibiting pepsin activity in
gastric juice. A synthetic colonic acidifier Lactulose 29, (Figure 1.8) 4-O-β-Dgalactosyl-D-fructose, promotes laxation.12
Figure 1.8. Disaccharides and their Conjugates.

29
1.1.7.3. Trisaccharides and their Conjugates
The third category, trisaccharides and their conjugates, is represented by two
prescription drugs; an antibacterial aminoglycoside antibiotic of microbial origin,
Tobramycin, and a cardiac glycoside, Digoxin 30. The latter drug belongs to a
closely related group of drugs of plant origin that contains a sugar and a
cardenolide; the sugar part consists of O-2,6-dideoxy-β-D-ribo-hexapyranosyl- (1>4)-O-2,6-dideoxy-beta-D-ribo-hexapyranosyl-(1->4)-2 ... -.13

12

Figure 1.9. Trisaccharides and their Conjugates.

30

1.1.7.4. Oligosaccharides and Polysaccharides.
Oligosaccharides are saccharide polymer containing a small number typically two
to ten of simple sugars (monosaccharides). and polysaccharides are complex
carbohydrates consist of more than ten of monosaccharides. The main
monosaccharides in their building blocks are glucose, fructose and galactose, 2
also known as simple carbohydrates. Prescription drugs made of oligosaccharides
and polysaccharides include two principal groups, heparin and heparin-like
saccharides. Heparin is a heterogeneous group of glycosaminoglycans, straight-

13

chain anionic mucopolysaccharides that have anticoagulant activity. Pentosan 31
polysulfate is a semi-synthetic sulfated heparin-like oligomer. Composed of β-Dxylopyranose residues, it shows anticoagulant and fibrinolytic effects. 12 The
complex oligosaccharides, can be represented by acarbose 32. This compound
derives from a microbial origin. It inhibits α-glucosidase and delays the digestion of
ingested carbohydrates, making the drug beneficial for the management of type 2
diabetes mellitus.12
Figure 1.10. Oligosaccharides and Polysaccharides.

31

32
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1.1.6.5. Macrolides.
The final subcategory of prescription carbohydrate drugs is represented by
macrolide group of antibiotics. Erythromycin 33, is of microbial origin; it appears
to inhibit protein synthesis in susceptible organisms by binding to ribosomal
subunits and thereby inhibiting translocation of aminoacyl transfer-RNA. The other
three Clarithromycin 34, Dirithromycin 35, and Azithromycin 36 are semi-synthetic
macrolide antibiotics derived of Erythromycin. Dirithromycin is a pro-drug that is
transformed during intestinal absorption into an anti-bacterial active form,
Erythromycylamine. Clarithromycin is 6-O-methylerythromycin. Azithromycin is
N-methyl-11-aza-10-deoxo-10-dihydroerythromycin”.12,13
Figure 1.11 Macrolides

33

34

15

35

36

1.1.6.6. Summary.
Carbohydrates are the most abundant molecules in natural products. The word
carbohydrate is derived from the observation that simple sugars are hydrates of
the element carbon. Carbohydrates are main energy source for mammals, the
major constituents of the shells of insects, and the supporting tissue of plants.
Carbohydrate chemistry has been a topic of interest and carbohydrate derivatives
are attractive for drug design because of their unique structure and biological
activity. Cell surface carbohydrates are involved in recognition, fertilization, signal
transduction, Multiple stereocenters and numerous hydroxyl functional groups
make carbohydrates a diverse class of structurally unique compounds. Glucose is
biologically-significant monosaccharide involved in metabolic and energetic
pathways. A large number of carbohydrates and carbohydrates derivatives are
used as therapeutics. Understanding the bioactive conformation of sugars and
carbohydrates-protein interactions, allows for the rational design of small drug-

16

like molecules with increased affinity, stability, and bioavailability. In addition to
therapeutics, carbohydrates are important in the paper and textile industries. As
the result of the prevalent importance of carbohydrates, there is a significant
future for basic research involving carbohydrates.
1.2. Benzopyrans.
1.2.1. General structure and properties of benzopyrans.
The chemistry of heterocyclic compounds is one of the most complex branches
of organic chemistry. It is equally interesting for its theoretical implications, for the
diversity of its synthetic procedures,14 and for the physiological and industrial
significance of heterocyclic compounds. Among all heterocyclic compounds,
oxygen heterocycles are special because of their wide occurrence in nature and
broad pharmaceutical significance. Benzopyrans appear as an important structural
components in various natural products, and mainly consist of a benzene ring
fused to a pyran ring.15 Benzopyrans can be classified according to their various
levels of saturation and oxidation, namely , chromane 37, 2H-chromene 38,
1H-isochromene 39, 4H-chromene] 40, 4- chromanone 41, 2,4-chromanedione 42,
and chromone 43
Figure 1.12. Examples of Different Levels of Saturation and Oxidation of Chromanes

37

38

39

40

17

41

42

43

In addition to functional derivatives of these ring systems, compounds in which a
benzene or other carbocyclic ring is fused to the benzene ring for example,
benzochromones 44, naphthopyrans 45, reduced chromones 46 and spiro
compounds 47 are also common in nature.14

44

45

46

47
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1.2.2. Benzopyran Biological Activities.
Benzopyrans (Chromenes) are one of the privileged medicinal pharmacophores
that appear as

important structural components in natural compounds and have

generated great attention because of their interesting biological activity. 15 It is a
heterocyclic ring system consisting of a benzene ring fused to a pyran ring.
Chromenes constitute the basic backbone of various types of polyphenols and
widely found in natural alkaloids, tocopherols, flavonoids, and anthocyanins.16 It is
known that certain natural and synthetic chromene derivatives possess important
biological activities such as: antitumor (Catechin) 48 , antibacterial ( Hongoqercin)
49 antivascular,17 antiviral , antimicrobial,18 antioxidant,19 (Tocopherol) 50 , as TNFα inhibitors,20 antifungal, (Siccanin) 51.21 anticoagulant, antispasmolytic,22
estrogenic,22 antiviral,23 anti-helminthic,24 anticancer,24 anti-HIV (Calanolide A) 52,25
antitubercular,26 anti-inflammatory,27 herbicidal, analgesic and as anticonvulsants.28
A key feature is that the lipophilic nature of the benzopyran derivatives helps
them to cross the cell membrane easily.29, 30
Figure 1.13. Examples of biologically active compounds.

48

49
19

50

51

52

12.2.31. Anticancer Activity Of Chromenes.
Cancer constitutes the second main mortality cause in the world. 31 Cancer is a
disease characterized by the uncontrolled growth of abnormal cells. It is
documented that the most cytotoxic anticancer agents induce apoptosis which is
programmed cell death. Chromene derivatives are an attractive template for the
identification of potential anticancer agents.32 In recent years, there has been
much interest in this class of compounds and their potential utility as anti-cancer
drugs. Many natural compounds contain chromene moieties that have been
reported with anticancer activity. These compounds are isolated from plants, fish, etc.
Some of the examples of natural anticancer compounds include tephrosin, 33 (lung
20

cancer) calanone,34,35 (leukemia and cervical carcinoma) and acronycine36 (lung,
colon and ovary cancer). The potential pro-apoptotic chemotherapeutic agents
target tubulin, bind to the different sites of tubulin and inhibit tubulin
polymerization.37 This has led to the discovery of new structural classes of
compounds capable of binding to the colchicine site of tubulin. The drugs under
this category that binds to the colchicine binding site of tubulin resulting in the
deformation of the α, β- dimer structure that prevents the tubulin from assembling
into microtubules leading to apoptotic cell death. 38,39 Substituted 4-aryl4Hchromene compounds belongs to a novel class of microtubule inhibitors and a
systematic change in the substitution of 4-aryl group increases the anticancer
activity of the compound.40,41 Examples of compounds coming from this category
are 2-amino-4-(3-bromo-4,5-dimethoxyphenyl)-7-(dimethylamino)-4H-chromene-3carbonitrile 53 and 2-amino-7-(dimethylamino)-4-(7-methoxy-1,3-benzodioxol-5 54. In
the above compounds, 2-amino-4-(3-bromo-4,5-dimethoxyphenyl)-4H-chromene-3carbonitrile 53 induces caspase-mediated apoptosis in tumor cells and is more
potent than the commonly prescribed anticancer alkaloids. Furthermore, this
compound treats drug-resistant cancers and also possesses vascular targeting
activity.42 to developed this type of compound, combretastatin A-4 which is a
phosphate prodrug (CA-4P), was used as a lead compound because of its simple
structure and, potent cytotoxic and vascular disrupting activity.23, 37 Bcl-2 protein
binding compounds also provide lead compounds for the development of
potential anticancer agents. Substituted 4H-chromene compounds bind to Bcl-2
protein (β cell lymphoma) and induce apoptosis in tumor cells.20 Ethyl 2-Amino-6-
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Bromo-4-(1-Cyano-2- Ethoxy-2-Oxoethyl)-4H-Chromene-3-Carboxylate (HA14-1) 55 is
an antagonist for antiapoptotic Bcl-2 proteins and has been used to overcome
drug resistance in cancer.38
Figure 1.14. Examples of Microtubule Inhibitors.

53

54

55
The SAR studies of the chromene nucleus found that the 4-aryl moiety,
3-cyano group and 2-amino group are all essential for cytotoxic activity.24,40 The
replacement of the 2-amino group with the oxo group gives the same activity
and helps in the synthesis by removing the chiral center.43 Substituting the
seven position with an electron donating group enhances the potency of the
compound while an electron withdrawing group in that position decreases the
activity.
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1.2.4.3. Summary.
Benzopyran is one of the privileged scaffolds that appears as an important
structural component in various natural products and also possesses useful
photochemical properties. The derivatives of the benzopyran moiety can be
capable of interacting with a variety of cellular targets which leads to their wide
ranging biological activities such as antitumor, antihepatotoxic, antioxidant, antiinflammatory, diuretic, anticoagulant, antispasmolytic, estrogenic, antiviral, antifungal,
antimicrobial, anti-helminthic, hypothermal, vasodilatory, anti-HIV, antitubercular,
herbicidal, anticonvulsant and analgesic activities. The potency of these clinically
useful pharmacophores in the treatment of cancer and inflammation and other
activities encouraged us to develop ways to synthesize these significant
compounds.
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Chapter 2
Pyranobenzopyrans

2.1. Overview and Historical Perspective
Coumarin derivatives (pyranobenzopyrans) have revealed promising biological
activity with interesting potential

therapeutic applications44 besides their traditional

use as anticoagulants,45 antifungal,46 anti-inflammatory agents.47 They have also
shown important property as antibiotics (novobiocin) 56,48 anti-AIDS agents
(calanolides) 57.47 and antitumor drugs.49,50
Figure 2.0. Examples of Coumarin bioactive compounds.

56

57

The biological activities of pyranobenzopyrans and their derivatives has made
their synthesis very important. Although numerous prescription medicines are
available for the treatment of human disease, medicinal chemist are continuously
searching for compound with improved efficacy.

24

2.2. Synthetic Approaches to Pyranobenzopyrans and their Derivatives in
Literature
2H-1-Benzopyrans (2H-chromenees) and 3,4-dihydro-2H-1-benzopyrans
(chromanees) have proven to be very important due to the biological activity of
naturally occurring representatives.51 4-Aminobenzopyrans and their derivatives
show a wide range of biological activities.52 Particularly, fused
tetrahydropyranobenzopyran derivatives are frequently found in naturally occurring
bioactive molecules. In 1999, Miyazaki and co-workers reported a p-toluenesulfonic
acid-catalyzed intramolecular [4+2] cycloaddition. Reaction of o-quinonemethides for
the synthesis of angularly trans-fused pyranobenzopyrans.53 The aza-Diels–Alder
reaction of o-hydroxybenzaldimines with 3,4-dihydro-2H-pyran (DHP) and 2,3dihydrofuran (DHF) is a convenient protocol for the synthesis of fused
pyranobenzopyrans and furanobenzopyrans.54,55 Several protic acids and Lewis
acids have been used to catalyze this reaction, such as LiBF4,56
PPh3-HClO4,57 and Bi(OTf)3.58 Although these methods are available, new,
efficient, selective, and facile protocols are still in strong demand. In the
literature, much work has been done in this field, we report some examples.
2.2.1. Facile, Solvent-free, One-Pot Synthesis of Pyranobenzopyrans and their
Derivatives
In May 2011, Sirisha and her group have developed a sequential one-pot
reaction for the synthesis of verity of substituted pyranobenzopyrans by
condensation of hydroxyl coumarins in a facile one-pot procedure with active
methylene esters under solventless conditions. The product underwent further
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condensation and cyclization reactions to form novel heterocycles. 59 (Schemes
2.0), (Schemes 2.1), (Schemes 2.2)
Scheme 2.0. One-pot Synthesis of Pyarnobenzopyrans.

58

59

R1 = 7-H, 7-OH, 6-Me

Scheme 2.1. One-pot Synthesis of Amide Substituted Pyranobenzopyran.

60
R1 = H, Me

61
R 4 = CONR2R3
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Scheme 2.2. Efficient, Synthetic Protocol for Thia-Diazole.

62

63

. R1 = 7-H, 7-OH, 6-Me

R4 = CONR2R3

2.2.2. Synthesis of Pyranobenzopyran Derivatives as Potent Antibacterial Agents
Mulwad and his group reported the synthesis of pyranobenzopyran derivatives as
a potent antibacterial agents by using 3-formyl-4-hydroxy-2 H (1)-benzopyran-2ones (1a-d) in reactions with diethyl malonate in the presence of piperidine to
give ethyl-2 H,5 H-2,5-dioxopyrano[3,2- c ] benzopyran-3-oate 2a-d.. Michael addition
of (2a-d) with ethyl acetoacetate gives ethyl 2,4-dihydroxy-5H, 12 H - 5, 12-dioxo
[2] benzo pyrano [4,3-c ] [1] benzopyran- 1-oate (3a-d). on Pechmann condensation
with ethyl acetoacetate gives 2-acetyl-1,6-dihydroxy-3 H, 7H,14 H-3,7,14-trioxopyrano [2 / ,3 / ,5,6] [2] benzo pyrano [3,2- c ] benzopyran (4a-d). Michael addition
followed by cyclization of acetylacetone with ethyl-2 H, 5H-2,5-dioxo-pyrano[3,2-c ]
benzopyran-3-oate (2a-d) in the presence of sodium methoxide in boiling
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methanol afforded 1-acetyl-2-methyl-4H, 5 H,12 H, 4,5,12-trioxo-dipyranobenzopyran.60
(Scheme 2.3).
Scheme 2.3. 1-acetyl-2-methyl-4H, 5 H,12 H, 4,5,12-trioxo-dipyranobenzopyran
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2.2.3. Molecular Iodine-catalyzed Diastereoselective Synthesis of cis-Fused
Pyranobenzopyrans and Furanobenzopyrans.
Recently, molecular iodine has received considerable attention as an inexpensive
and readily available catalyst for various organic transformations due to its
moderate Lewis acidity and water tolerance. Jun Wang, and his group in May
2008 described a diastereoselective synthesis of cis-fused pyranobenzopyrans
and furanobenzopyrans via a molecular iodine-catalyzed reaction of
o-hydroxybenzaldimines with 3,4-dihydro-2H-pyran and 2,3-dihydrofuran at ambient
temperature. Using this method, 2-butoxy-4-N-arylaminobenzopyrans were also
synthesized from o-hydroxybenzaldimine and n-butyl vinyl ether. The notable
features of the procedure include mild and metal-free reaction conditions,
operational simplicity, using a catalytic amount of molecular iodine (2 mol %),
short reaction time, and good yields.61 (Scheme 2.4), (Scheme 2.5),
Scheme 2.4. Synthesis of Furanobenzopyrans.
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Scheme 2.5. Synthesis of Pyranobenzopyrans.
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2.2.4. Diastereoselective, One-Pot Synthesis of Pyranobenzopyran,
Furanobenzopyrans and Tetrahydroquinolines Derivatives.
The classical Diels-Alder reaction, a [4+2] cycloaddition of diene and dienophile
to generate a six membered carbocyclic system in modified form can be used to
generate nitrogen or oxygen containing six membered rings. In February 2004,
Senthil Kumar and his group reported a one-pot procedure which is useful when
the diene is unstable and difficult to purify either by distillation or
chromatography. Lewis acids such as lanthanide triflates, were found to catalyze
this reaction, however most of these reactions suffer from various disadvantages
such as, more than a stoichiometric amount of catalyst is needed due to strong
coordination of it with the heteroatoms, longer reaction times, higher costs and
use of only aprotic solvents under anhydrous conditions. Also, these reactions
cannot be performed in one pot because the amine and water that are present
during the formation of imine can decompose or deactivate the Lewis acids.
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However the use of KHSO4 as a catalyst is inexpensive, mild, and does not
require the maintenance of anhydrous conditions. Treatment of salicylaldehyde,
amine, and dihydropyran in the presence of KHSO4 in methanol at room
temperature gave an inseparable mixture of linearly cis- fused pyranochromanees
with higher diasteroselectivity.62 (Scheme 2.6).
Scheme 2.6. One-Pot Synthesis of Furanobenzopyrans.
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Scheme 2.7. One-Pot Synthesis of Pyranobenzopyran
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2.2.5. Diastereoselective Synthesis of cis-fused Pyrano- and Furanobenzopyrans
Catalyzed by Indium Trichloride or Triphenylphosphonium Perchlorate
In October 2002, Marimuthu Anniyappan and his research group reported the
application of Indium trichloride and triphenylphosphonium perchlorate to be
effective catalysts for the cyclization of o-hydroxyaldimines with 3,4-dihydro-2Hpyran and 2,3-dihydrofuran at ambient temperatures to afford novel pyrano- and
furanobenzopyrans and their derivatives (Schemes 2.8 and 2.9). One pot syntheses
of pyrano- and furanobenzopyrans from o-hydroxybenzaldehyde, aromatic amines
and an enol ether under identical conditions was reported for the first time
(Scheme 2.10). Similarly, various substituted salicylaldimines reacted well to give
the corresponding cis-fused pyranobenzopyrans in good yields.62
Scheme 2.8. Synthesis of Pyranobenzopyrans Using Indium Trichloride and
Triphenyl Phosphonium Perchlorate
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Scheme 2.9. Synthesis of Furanobenzopyrans Using Indium Trichloride and
Triphenyl Phosphonium Perchlorate.
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Scheme2.10. One pot Syntheses of Furanobenzopyrans Using Indium Trichloride
and Triphenylphosphonium Perchlorate.
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2.2.6. Sc(OTf)3 Catalyzed Synthesis of Pyrano[3,2-b]-1-Benzopyrans from D-glycals
In this report, Yadav and his research group had describe a new and efficient
method for the synthesis of fused pyranobenzopyrans from
o-hydroxybenzaldehydes and glycals using a catalytic amount of scandium triflate.
Thus treatment of o-hydroxybenzaldehyde with 3,4,6-tri-O-methyl-D-glucal and
trimethyl orthoformate (TMOF) in the presence of 3 mol% of Sc(OTf)3 in
dichloromethane at ambient temperature resulted in the formation of the cis-fused
33

pyrano[3,2-b]benzopyran in 80% yield (Scheme 2.11). Similarly, several
salicylaldehydes reacted well to give the corresponding cis-annelated acetals in
excellent yields. In all cases, the reactions proceeded smoothly at ambient
temperature with high selectivity. Only one diastereomer was obtained in each
reaction, the structure of which was established with the help of various NMR
experiments like double quantum filtered correlation spectroscopy, nuclear
Overhauser effect spectroscopy and selective homonuclear decoupling studies. 63
Scheme 2.11. Synthesis of pyrano[3,2-b]-1-benzopyrans from D-glycals
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2.2.7. LiBF4-Catalyzed Formation of Fused Pyrano- and Furanobenzopyrans
In this report, Yadav and his group described a new and highly efficient
protocol for the synthesis of fused pyrano- and furanochromanes (Scheme 2.12),
(Scheme 2.13), using a catalytic amount of LiBF4 in acetonitrile. The treatment of
the Schiff base of salicylaldehyde with 2,3-dihydrofuran in the presence of lithium
tetrafluoroborate at ambient temperature afforded the cis-fused furanochromane in
90% yield. Similarly, several o-hydroxybenzaldimines (formed in situ from
3 o-hydroxybenzaldehydes and anilines in the presence of anhydrous Na 2SO4 in
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acetonitrile) reacted well to give the corresponding cis-fused acetals in excellent
yields. The reactions proceed smoothly at ambient temperatures with high
diastereoselectivity.64 In all reactions, the product was obtained as a single
isomer, the structure of which was confirmed by detailed 1H-NMR and NOESY
experiments.
Scheme 2.12. Synthesis of Furanobenzopyrans Using a Catalytic Amount of LiBF4.
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Scheme 2.13. Synthesis of Pyranobenzopyrans Using a Catalytic Amount of LiBF4
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2.3. Glycals in Heterocyclic Organic Synthesis.
Glycals are cyclic vinyl ether derivatives of sugars that contain a double bond
between carbon atoms 1 and 2 of the ring These 1,2 unsaturated sugars 89 are
either commercially-available or easily prepared from 1-halogeno sugars.
Manipulations of this double bond have been the focal point of many syntheses
that use glycals as starting materials. Addition reactions have been employed in
the preparation of carbohydrate-based compounds, including fused heterocycles.
A survey of the current scientific strategies may prove useful when applied to
sugars with double bonds at other position of the molecule. 65
Figure 2.1. 1, 2- Unsaturated Sugars (glycals)

89
2.3.1. Hybrids of Sugars and Aromatics: A Pd-Catalyzed Modular Approach to
Chromanes and Isochromanes.
Markus Leibeling and his group reported the synthesis of chromanes and
isochromanes using carbohydrates as starting materials. They report the full
details of this highly efficient procedure to access chromanes and isochromanes
by utilizing an appropriately substituted 2-bromoglycal as the starting material of
a domino reaction (Scheme 2.14).66 Their method allowed for the easy
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introduction of defined stereocenters on the pyran unit. For the creation of the
benzene moiety an intramolecular Pd-catalyzed reaction was used that employs a
diyne chain attached to the pyran core. Such a procedure allows the synthesis
of heavily functionalized chromane and isochromane derivatives that are difficult
to obtain by other routes. The target molecules may be regarded as hybrids
between carbohydrates and an aromatic compound.
Scheme 2.14. Synthesis of chromanes and isochromanes

Chromane

Isochromane

89

91

90

92
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2.2.2. The hetero Diels-Alder approach to carbohydrate-containing molecular
scaffolds
Martina Cacciarini and her group at the University of Florence used a strategy
that relies on a totally steroselective hetero Diels-Alder reaction. It is an inverse
electron-demand [4+2] cycloaddition between α,α’ –dioxo-thiones, α-oxo- α’iminothiones or ortho-thioquinones as electron-poor heterodienes and unprotected
or differently protected glycals as electron-rich dienophiles.67 (Scheme 2.14).
Scheme 2.16. Carbohydrate-Containing Molecular Scaffolding.
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The research group of Professor Marzabadi became interested in developing a
general method for the synthesis of carbohydrate-based oxazolines accessed from
2-iodo-glycosylamides,68 Glycosylamides were prepared by reaction of
different protected glycals with N-iodosuccinimide and alkyl and aryl amides.
Mixtures of diastereomers were obtained from these reactions. These were then
cyclized in the presence of base to produce the heterocycle. Assignment of the
product stereochemistry was made by analyzing the vicinal coupling constants in
the product’s NMR spectra (Scheme 2.16)
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Scheme 2.17. Synthesis of Glycosylamides.
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Professor Marzabadi has also focused in the preparation of C-linked, quinoline
derivatives from glycals. They developed and expanded the scope of a facile,
one- pot method based upon Povarov reaction to prepare novel C-glycoslated
quinolines. The reaction proceeded through the stereoselective formation of sugarspiroanellated tetrahyroquinoline intermediates69. These compounds are
subsequently oxidized and undergo sugar ring opening to form the fully
aromatized quinolines (Scheme 2.18).
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Scheme 2.18. Synthesis of Spiroanellated Tetrahyroquinoline

2.4 Summary
Pyranobenzopyrans and their derivatives are oxygen heterocyclic compounds that
structurally consist of a pyran ring fused to chromane or chromene and/or their
derivative. The synthesis of pyranobenzopyrans and their derivatives has been a
subject of great importance in the field of organic chemistry because of the
biological activity of naturally- occurring representatives.
In our survey of the literature, many research groups synthesized
pyranobenzopyrans and their derivatives in different ways by using a variety of
starting materials, but there is only one report on the synthesis of
pyranobenzopyrans from using unsaturated carbohydrates (glycals) in place of
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3,4-dihydro-2H-pyran. This reaction was reported by Yadav and his colleagues.
We report additional studies directed at the synthesis of these molecules.
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Chapter 3

The Synthesis of Carbohydrate-Fused Benzopyrans

3. Results
3.1. Synthesis of the Starting Materials.
Due to the growing interest in carbohydrate drugs and the importance of the
pyranobenzopyran moiety, as mentioned before, we focused our efforts on doing
synthesis in this area and in the development of convenient methods for doing
this chemistry using glycals as precursors. We first needed to prepare the
starting materials from which we would conduct our research. The synthesis was
begun with the ester hydrolysis of commercially-available tri-O-acetyl-D-glucal 105
to produce D-glucal 106 (Scheme 3.0).70 This material is used as a starting
material for preparation of tri-O-benzyl-D-glucal 97 and tris-O-t-butyl-dimethylsilylD-glucal 107 using published literature procedures71 (scheme 3.1) and (Scheme
3.2). The idea behind the use of the different protecting groups was to study the
effect of the protecting group on stereoselectivity and the two different groups
activate the double bond to cycloaddition during the synthesis of
pyranobenzopyran. The imine 108 was also prepared using known literature
procedures. The synthetic procedure involved a room temperature reaction
between 2-hydroxybenzaldehyde and aniline. (Scheme 3.4).
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Scheme 3.0 De-O-acetylation of D-Glucal

105

106

Scheme 3.1. Benzylation

106

97

Scheme 3.2. Silylation

106

107
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Scheme 3.3. Synthesis of the Imine

71

72

108

3.2. Catalyst Screening
In order to investigate conditions for the cycloaddition reaction between the
glucal and benzaniline, we screened several rare earth metal triflates as Lewis
acid catalysts (Table 3.0). Based on our literature survey,68 we chose to study
Sc(OTf)3, InCl3, Yb(OTf)3, PdCl2 and TESOTf as they had shown effectiveness
in other similar reactions.
3.3. General Synthetic Procedure.
Despite the multitude of publications covering the synthesis of
pyranobenzopyrans, we focused our work on using a less common method for
synthesis. Our reactions utilize an inverse electron- demand Diels-Alder reaction. This
is a [4 + 2] cycloaddition of a diene and a dienophile to generate a six- membered
heterocyclic system; 63 in our case an oxygen containing six-membered ring
system. We tried three different methods for carrying out these reactions using
glycals 106 as both the dienophile and the heterodiene. The different methods
used are listed below as are the different conditions of temperature, catalyst,
reaction time and solvent (See Tables. 3.1, 3.2, 3.10 and 3.11 ).
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3.3.1. The Conventional Cycloaddition Methods.
In this method, we used a known procedure from the literature in which a
variety of protected glucals: tri-O- acetyl-D-glucal 105, tri-O- benzyl-D-glucal 97 and
tris-O-tert-butyldimethlsilyl-D-glucal 107 (scheme 3.4)73 were reacted with imine 108
in the presence of a catalyst in organic solvent. The effects of the alcohol
protecting group, solvents and catalysts on the reactions rates, the product
yields, and the product stereoselectivities of the addition reaction were studied
(Table 3.1). The choice of the solvents used was based upon the substrates and
catalysts being readily soluble in dichloromethene and acetonitrile. The reactions
were conducted under nitrogen and a range of temperatures were applied.
Scheme 3.4. Conventional Methods.

108

89

109

R = Bn, Ac, TBDMS, Solvent = CH3CN, CH2Cl2, Catalyst = Sc(OTf)3, InCl3, Yb(OTf)3, PdCl3 and
TESOTf

3. 3.1.1. Reaction Mechanism
The postulated reaction mechanism for the synthesis of pyranobenzopyrans is
as follows (Scheme 3.5): first, the Lewis acid catalyst complexes to the nitrogen
of the imine 109 resulting in the formation of the iminium ion intermediate 110 in
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which the nitrogen atom bears a positive charge. The resulting o-quinonemethide
acts as an oxadiene 111. The electrons from the activated alkene react with the
unsaturated sugar to create a bond that couples the two compounds together to
give the pyranobenzopyran 112.
Scheme .3.5. Reaction Mechanism for the Synthesis of Pyranobenzopyrans
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R = Bn, Ac, TBDMS

From our observations, the reactions of tri-O-acetyl-D-glycal 105 took a long time
and did not progress with different solvents and different catalysts even after 7
days (Table 1). That is most likely due to the deactivating nature of the electron
withdrawing acetate groups in compound 105. In the cycloaddition reaction,
electrons of the π-system of the sugar must be available for bonding to occur,
therefore; having electron withdrawing protecting groups will decrease the electron
density of the double bond and slow down the reaction. On the other hand, with
tri–O-benzyl-D-glucal 97, the benzyl group is electron donating and we postulated
that the reaction would work better. However, the same results were obtained
46

with this protecting group when the reactions were conducted at room
temperature. When the experiments were conducted at 60 and 80 0C, we
observed a gradual color change from yellow to brown. The progress of the
reaction was checked by TLC (90:10 hexane/ethyl acetate) and a mixture of
products were observed along with a large amount of unreacted starting material.
These results can be explained by the effect of the benzyl and silyl protecting
groups that causes steric-hindrance for the reaction and hinders its progress,
where acetyl glucal has electron withdrawing nature will decrease the electron
density of the double bond and hence slow down the rate of the reaction.
3.3.1.2. Summary.
The synthesis of pyranbenzopyrans using the conventional method was
unsuccessful. That may be due to many factors including: the effect of the size
and the nature of the protecting groups that can block or electronically
deactivate the glycal double bond in the Diels-Alder reaction.
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Table 3.1. The Conventional Methods and conditions
Dienophile

Temp 0C

Time

Catalyst

Solvent

Tri-O-acetyl-D-

25

7 days

Sc(OTf)3

CH3CN

25

7 days

InCl3

CH2Cl2

25

7 days

Sc(OTf)3

CH3CN

25

7 days

InCl3

CH2Cl2

25

7 days

Sc(OTf)3

CH3CN

25

7 days

InCl3

CH2Cl2

25

7 days

PdCl2

CH3CN

25

7 days

Yb(OTf)3

CH3CN

25

4 days

TESOTf

CH3CN

60

18 hr

Sc(OTf)3

CH3CN

60

18 hr

TESOTf

CH3CN

80

18 hr

Sc(OTf)3

CH3CN

glucal

Tris-O-tertbutyldimethylsilylD-glucal

Tri-O-benzyl-Dglucal
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3.3.2. The Microwave Reactor.
Our failure in obtaining pyranobenzopyrans using the conventional synthetic
method led us to think about other possible procedures. Because the Diels-Alder
reaction requires higher energy to take place,74 we chose microwave activation
as a non-conventional energy source. Microwave energy has become a very
popular and useful technology in organic chemistry. The conventional heating
techniques such as a hot plate, oil bath, heated jackets and sand baths, are
rather slow and a temperature gradient can develop within the sample. In
addition, local overheating may lead to decomposition of reactants as well as the
products. On the other hand, microwave radiation passes through the walls of
the reaction vessel and heats only the reactant and solvent. The heating effect
utilized in microwave- assisted organic transformations is due to dielectrical
polarization, although conduction losses can also be important particularly at
higher temperatures.72 Only dipolar and interfacial polarization are important
factors in heating effects associated with microwave irradiation, the use of polar
components facilitates the absorption of microwave energy and consequently the
conversion into heat and with the use of a sealed vessel it was possible to
increase the temperature and eventually the pressure and the reaction rates. 75
The short reaction times and expanded reaction range offered by microwave
assisted organic syntheses are suited to the increased demand of the chemical
industry. “It is nearly a Herculean effort to give a complete overview where
microwave heating has been applied to heat up chemical reactions.” 76-86
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“Even below room temperature microwave irradiation is used to run reactions in
combination with simultaneous cooling.” 87, 88
3.3.2.1. The Background of the Microwave Technology.
Diels‐Alder Reactions
In 1986 several Diels‐Alder reactions were investigated in the microwave oven.
For example, the reaction of anthracene 113 with maleic 114 anhydride provided
the required product yield in 89% in 5 minutes .89 (Scheme 3.6).
Scheme 3.6. Diels‐Alder Reaction of Anthracene with Maleic Anhydride.

113

114

115

In our survey of the literature the use of microwave energy in carbohydrate
chemistry is very limited, we reviewed the application of microwave reactors in
carbohydrate chemistry; below are some examples:
Peracetylation
Peracetylation 117 of D-glucose 116 to give the penta-O-acetyl derivative with a
small excess of acetic anhydride under catalysis with either anhydrous potassium
or sodium acetate was carried out and the reaction reached completion within
15 minutes in the microwave reactor.90 (Scheme 3.7)
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Scheme 3.7 Peracetylation

116

117

Catalyst = anhydrous potassium or sodium acetate

Benzoylation.
In order to verify the possibility of modulating the selectivity in microwavepromoted protection of hydroxyl functionalities, Herradòn et al.91 studied the
influences of both the solvent and the power output of the oven on the
selectivity of dibutylstannylene acetal-mediated benzoylation of methyl α-Dmannopyranoside 118 with PhCOCl, n-Bu2SnO and Et3N, the resulting compounds
119, 120 and 120 shown in (Scheme 3.8) “ verify the possibility of modulating
the selectivity in microwave-promoted production of hydroxyl functionalities.”

91

Scheme 3.8. Benzoylation

118

119

120

120
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Acetal Formation.
This method, was modified by Oscarson when he treated α-D-glucopyranoside
121 with benzal bromide and N-(methylpolystyrene-4-(methylamino)pyridine in
acetonitrile to form 4,6-O-benzylidene derivative 122 at 170°C for 5 min to yield
83% of the product (Scheme 3.10).92
Scheme 3.9. Acetal Formation.

121

122

Pterins.
Isay condensed pyrimidine diamine 123 with aldohexoses, to afford pterins with
a sugar substituent (Scheme 3.10) under microwave irradiation (300 W) for 270
sec. Interestingly, the desired, isomerically free, 6-substituted sugar derivatives
were synthesized in moderate to good yields, whereas mixtures of two isomers
are generally obtained using conventional Isay type condensations. 93 When
benzene diamine, was used, quinoxaline 124 was obtained. (Scheme 3.11).
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Scheme 3.10. Synthesis of Pterins.

123
R = R’= H

124
R =R’ = Ac

Scheme 3.11. Synthesis of Quinoxaline
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3.3.2.2. Microwave Reaction Results
The variety of applications of microwave technology in carbohydrate chemistry
especially in the field of synthesis and the high yields obtained in short reaction
times, encouraged us to use

microwave irradiation in synthesis of

pyranobenzopyrans. Since the conventional methods failed to produce our target
molecules, we used the same procedure that we applied in the conventional
method to see if there would be an improvement, (Scheme 3.12) The only
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difference was the total volume of the reactant mixture used was 7 mL and that
was based on the microwave tube volume. Different solvents and different conditions
were used also (Table 2). The temperature and the pressure were adjusted
according to the boiling point of the solvent. Solvents play an important role in
organic synthesis and microwave heating, therefore the choice of the solvent can
be a crucial factor in the outcome of a reaction in microwave reactor. One of the
important characteristics of the solvent is its polarity. With microwave heating, this
becomes a more significant component, as microwaves directly couple with
molecules that are present in the reaction mixture. This interaction leads a rapid
rise in temperature and faster reaction rates.
Scheme 3.12. Synthesis of Pyranobenzopyrans Using a Microwave.

108

89

109

R = Bn, Ac, TBDMS
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Table 3.2. Microwave conditions
Dienophile

Solvent

catalyst

Temp 0C

Pressure

Power W

Time min

Bar
Tri-O-acetyl-D-

DCM

TESOTF

65

6

300

20

glucal

DCM

Sc(OTf)3

65

6

300

20

Acetonitrile

TESOTF

82

10

300

20

Acetonitrile

Sc(OTf)3

82

10

300

20

Tri-O-benzyl-D-

Acetonitrile

TESOTF

82

10

300

20

glcual

Acetonitrile

Sc(OTf)3

82

10

300

20

Acetonitrile

TESOTF

82

10

300

20

Acetonitrile

Sc(OTf)3

82

10

300

20

Tris-O-tert-

Acetonitrile

TESOTF

82

10

300

20

butyldimethylsilyl-

Acetonitrile

Sc(OTf)3

82

10

300

20

D-glucal

The results in (Table 3.2) show the different conditions that we used for the
microwave reactor. We used dichloromethane and acetonitrile as solvents
because all the reactants are soluble in them. The boiling point of
dichloromethane is very low (40 0C) and the maximum temperature we could
apply for the reaction was 65 0C.84 The time was increased gradually from 5
minutes to 20 minutes and the progress of the reaction was checked by TLC
every two minutes. The reaction color gradually changed from yellow to brown
and when the time reached 20 minute the color had turned black, and when we
checked by TLC decomposition of the imine was observed. The use of
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acetonitrile as a solvent with tri-O-acetyl-D-glucal and tris-O-tert-butyldmethylsilylD-glucal did not enhance the conversion and with an increase in the reaction
time and/or the the reaction temperature decomposition of the imine was
observed. When acetonitrile was used as a solvent with tri-O-benzyl-D-glucal at
a temperature of 82 0C for 16 minutes, only a small amount of product formation
was observed by TLC. This was a mixture of products that were difficult to be
isolated and identify, with an increase in time and/or temperature, the products
and starting imine were shown to have decomposed. Because we were
unsuccessful in producing our target molecule using this method, we thought
about a one pot synthesis, in which the production of fresh imine in the
microwave reactor may help the reaction to move forward and lead to the
formation of the target product (Scheme 3.14). The reaction was setup by mixing
tri-O-benzy-D-glucal 97, o-hydroxybenzaldehyde 71, and aniline 72, in acetonitrile
was catalyzed by scandium triflate (5 mole %). Different temperature ranges and
times were applied. Unfortunately the TLC showed only the starting material, after
18 minutes and this method was abandoned.
Scheme 3.13. The Microwave Reactor in One Pot Synthesis.

71

72

97

127
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3.3.2.3.Summary
We hypothesized that since microwaves are powerful, reliable energy sources in
which the microwaves couple directly with molecules that are present in the
reaction mixture, that this rapid rise in temperature may promote our reaction
towards the formation of the required product and thereby increase the yield.
Unfortunately no reaction took place with the various microwave conditions.
The reasons for failure to react may be due to the presence of large protecting
groups as previously discussed or to the effect of their electron withdrawing
nature. Although many attempt to synthesize this molecule were made by using
the microwave reactor, unfortunately we were unsuccessful. Then we decided to try
non-traditional solvents, the ionic liquids. These solvents possess many good
chemical and physical properties and it was our hope that they would enable
the synthesis of our target molecules.
3.3.3.The Use of Ionic Liquids as Solvent in the Synthesis of Pyranobenzopyran
3.3.3.1. Ionic Liquids- an Overview.
Ionic liquids (ILs) are organic salts that are liquid at ambient temperature. They
consist of organic cations such as: imidazolium, pyridinium, sulfonium,
phosphonium, etc. (Figure 3.0) and organic or inorganic anions (Figure 3.1).94 Ionic
liquids have emerged as a new class of solvents that can be used as an
alternative to environmentally- volatile organic solvents. They are practical
alternatives, due to their unique combination of low volatility, low melting point,
chemical stability, high conductivity, wide electrochemical window, and their ability
to dissolve organic and inorganic solutes and gases.

95-99
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Figure 3.0. The Most Common Ionic Liquid Cations.

Imidazolium

Pyridinium

Thiazolium

Lithium

Figure 3.1. The Most Common Anions
[BF4]Tetrafluoroborate

[PF6]Hexafluorophosphate

[OTf]Triflate

[Al2Cl7]Aluminium chloride

Ionic liquids are not easily crystallized and remain liquids through a wide range
of temperatures. They are not often involved in the processes of solvolysis and
solvation, usually associated with traditional aqueous and organic solvents, and
can also be designed to solubilize either polar or non-polar molecules. Hence,
ionic liquids are attracting attention as potential replacements for the
conventional, volatile, environmentally harmful organic solvents.
The particular importance of the ionic liquids: ability to Design Specific Physical
and Chemical Properties.
Arguably the most useful property of the ionic liquids is the ability to ‘design’ or
‘tune’ a set of specific desirable physical and chemical properties through the
simple adjustment of the side chains of the cation (R groups) (Figure 2) and / or
the appropriate selection of the anion (Figure 3.0).100 The range of physical and
chemical properties available with ionic liquids is considerably wider than those
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of commonly used organic solvents. Thus, an appropriate “Task Specific Ionic
Liquid (TSIL)” 100 can be designed with the precise physical and chemical
properties desired by the end user.;
Low or Near Zero Vapor Pressure.
ionic liquids are salts, and hence, have a very low or a nearly zero vapor
pressure. Because of this property very little ionic liquid is lost into the
environment through evaporation, even when ILs are used at elevated
temperatures as solvents and /or as catalysts;100
Low Melting Points.
Most of the room temperature ionic liquids have a very low melting point,
enabling them to be liquids at or below room temperature. This low melting point
can be attributed to the asymmetric nature of the ions making up these salts.
This asymmetry prevents the compact packing of the ions. The ionic liquid,
1-ethyl, 3-methyl imidazolium tetrachloraluminate for example has a melting point
of 9 0C;101
Water Miscibility.
Some ionic liquids are water miscible and some are not. This property can be
switched on and off according to the process requirements by modifying the
cationic structure of the ionic liquids or by changing its anion. The anion chosen
plays a prominent role in ionic liquid water miscibility. [PF6]-, (CF3SO2)2N]- are
example of water immiscible anions, where [CH3COO]-, [CF3COO]-, [NO3]-,
[CH3CH2SO3]-, Br-, I-, and Cl- are water miscible anions;101
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Recoverability and Reusability.
Since the miscibility properties differ significantly based on ionic liquid structure,
the products of reactions can often be recovered from ionic liquids by means of
extraction. Supercritical CO2, water or organic solvents can be used to recover
products and enable the recycling of the ionic liquid for subsequent reactions;.
Large Liquid Range and Thermal Stability.
Ionic liquids have a very large liquids range, and they are very stable with
respect to elevated temperatures. For example, 1-ethyl-3-methyl imidazolium
bis(trifloromethylsulfonyl) imide has a liquid range of 471 degrees, with a melting
point 15 0C and a decomposition temperature at 455 0C.102 This property makes
RTILs useful for reactions that need to be maintained at either low or high
temperatures.
Air and Moisture Stable Ionic Liquids.
One of the major drawbacks which hinders the use of chloroaluminate ionic
liquids is their sensitivity to air and moisture. The development of ionic liquids
that are air and moisture stable has provided renewed interest in ionic liquid
chemistry. The concept of ionic liquids received a substantial boost by the Wilkes
group when they described in 1992 the synthesis of ionic liquids with significantly
enhanced stability against hydrolysis;103,105
Acid-Base Properties and Water Interactions.
While simple salts such as KCl can be thought of as the product of an electron
transfer between elements, organic salts can be traced to a proton transfer
between an acid and base. Cations such as emim+ and n-bupy+ result from the
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alkylation of the bases emim+ and py+. Anions such as [NO 3]-, [AlCl4]- and
[PF]6- derive from Lewis acid base reactions. It is also possible for Lewis neutral
ions to add further Lewis acids to form acidic ions, e.g., [Al2Cl7]-. As a result we
can obtain Lewis basic, neutral or acidic ionic liquids, exemplified by the wellresearched haloaluminates. In addition we can make protic acidic liquids which
are simultaneously of any Lewis aspect,106 and relate the proton chemistry in
ionic liquids to proton chemistry in water. The acidic protons in ionic liquids are
bonded to bases such as pyridine and ethylimidazole are not labile, 107 These
bases do not behave in line with their pKb’s in water; bases in ionic liquids
appear to act in accordance with their gas phase proton affinities
(l-methylimidazole > pyridine > ammonia).108 The complicating factor is solvation in
water. One can, however, obtain Hammett acidity data for some systems which
make fair chemical sense;109
Densities.
The density range of ionic liquids is 1.1 to 1.6 g/cm -3, and it mainly depends on
the type of cation and anion used in the IL. The density of the ionic liquids
depends on the bulkiness of the organic cation, with an increase of the
bulkiness of the cation the density is decreased. This allows the chemist to
adjust the density as required for a specific synthesis (Table 3. 3). 110
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Table 3.3. Densities of Imidazolium Ionic Liquids.
Ionic Liquid

Density(g/cm-3)

1

[bmim]BF4

1.320

2

[bmim]PF6

1. 38

3

[emim]PF6

1.426

4

[emim]Br

1.575

5

[emim]EtSO4

1.240

Viscosity.
The viscosity of an ionic liquid is essentially determined by its tendency to form
hydrogen bonds and by the strength of its Van der Waals forces. 110 Comparison
of the viscosity of different hydrophobic ionic liquids with [bmim]+ ions
emphasizes the interplay between Van der Waals interactions and hydrogen
bonding as the structure of the cation influences the viscosity. Low viscosities are
usually obtained with [emim]+ ion in which a mobile side chain is combined with
a low molar mass. Longer or fluorinated alkyl chains result in higher viscosities
because of stronger Van der Waals interactions.111
3.3.2. Synthesis of Ionic Liquids
The story of ionic liquids is generally regarded as beginning with the first report
of the preparation of ethylammonium nitrate in 1914. This species was formed by
the addition of concentrated nitric acid to ethylamine, after which water was
removed by distillation to give the pure salt, which was liquid at room
temperature. The protonation of suitable starting materials (generally amines and
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phosphines) still represents the simplest method for the formation of such
materials, but unfortunately it can only be used for a small range of useful salts.
The possibility of decomposition through deprotonation has severely limited the
use of such salts, and so more complex methods are generally required.
Probably the most widely used salt of this type is pyridinium hydrochloride, Thus,
most ionic liquids are formed from cations that do not contain acidic protons.
The majority of ionic liquid chemistry based on nitrogen-containing heterocycles
focuses on the use of 1-alkyl- 3-methylimidazolium and N-alkylpyridinium cations.
1-Alkyl- 3-methylimidazolium hexafluorophosphate (AMImPF6), 1-alkyl-3methylimidazolium tetrafluoroborate (AMImBF4), N-alkylpyridinium tetrafluoroborate
(APyBF4) and N-alkylpyridinium hexafluorophosphate (APyPF6) are typically ionic
liquids used as solvent or catalysts. There are two basic methods for the
preparation of these ionic liquids: metathesis of a halide salt (Finkelstein step)
with silver, group1 metal or ammonium salt of the desired anion and acid–base
neutralization reactions. Either way, there is a need to prepare the imidazolium or
pyridinium halides via alkylation (Menschutkin step) using a large molar excess of
haloalkane (10–400%) for as long as 72 h at refluxing condition, and then RTILs
are prepared with variable yields and much longer reaction times. The most
common method uses stoichiometric amounts of 1-methylimidazole or pyridine,
alkylhalides and the potassium, sodium or ammonium salt of hexafluorophosphate
or tetrafluoroborate in one-pot under solvent-free condition.112 (Scheme 3.14).
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Scheme 3.14. Synthesis of Imidazolium Ionic Liquid

3.3.3. Ionic Liquids as Solvents:
In recent years, environmentally-friendly reaction processes have been extensively
studied from the standpoint of green chemistry. For example, oxidation reactions
with

air, or reactions in water, supercritical fluids, and fluorous solvents are

reported. Most recently, ionic liquids have gained much attention as green
reaction solvents for organic synthesis. As seen above, ionic liquids are salts,
consisting of cations such as imidazolium, pyridinium, quaternary ammonium and
quaternary phosphonium, and anions such as halogen, triflate, tetrafluoroborate
and hexafluorophosphate, which exist in the liquid state at relatively low
temperatures. Their characteristic features include almost no vapor pressure, nonflammability, non-combustibility, high thermal stability, relatively low viscosity, wide
temperature ranges for being liquids, and high ionic conductivity. When an ionic
liquid is used as a reaction solvent, the solute is solvated by ions only, where
the reaction proceeds under quite different conditions as compared to using
water or the regular organic solvents. Hence, they are expected to exhibit
unconventional reactivity, and their applications in a variety of organic reactions
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are being explored. Furthermore, some ionic liquids have a very low solubility in
water and polar organic solvents. Utilization of this property enables recovery and
reuse of ionic liquids, after extracting the product with an organic solvent. That
can help to reduce the waste of traditional solvents which are rarely reused.
Moreover, ionic liquids have attracted much attention as safe solvents, due to
their low volatility. The following are some reaction examples using ionic liquids. 113
Diels-Alder Reaction.
The Diels-Alder reaction between cyclopentadiene and the methyl acrylate ester
has been reported. In the Diels Alder reaction using 1-ethyl-3-methylimidazolium
chloride/chloroaluminate [emimCl/(AlCl3)X], the endo / exo ratio of the products
varies largely, depending on the ratio of emimCl/ (AlCl3)X. The amount of endo
form increases four-fold with the acidic emimCl/(AlCl3)X, compared to that of the
basic emimCl/(AlCl3)X).114,115 When the same reaction is carried out with 1-butyl3-methylimidazolium tetrafluoroborate (bmimBF4) there was similar reactivity to
Lewis basic emimCl/(AlCl3)X.
Scheme 3.15. Diel-Alder Reaction.

128

129

130

131
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Heck Reaction.
In the Heck reaction using palladium catalysts, polar solvents such as DMF and
acetonitrile are usually employed, and aryl iodides are normally used as
substrates. In cases where the less expensive but less reactive aryl bromides or
chlorides are employed, it is necessary to use more active catalysts or add
phosphine ligands in order to retain the catalytic activity. By utilizing 1-butyl-3methylimidazolium bromide (bmimBr) as a solvent, aryl bromides react with
styrene to afford stilbenes in high yields without adding a phosphine ligand.
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Scheme 3.16. Heck Reaction

132

133

134

Aldol Condensation Reaction
The Aldol Condensation reaction using ionic liquids has also been reported. In the
reaction for obtaining 2,4-dimethylhept- 2-enal 134 from propanal via two Aldol
condensations, the conversion values of the ionic liquid phase is comparable to a
water medium in the Aldol I reaction. However, the product selectivity is reduced,
as can be seen (Scheme 3.17) below. This is due to a side reaction proceeding
from the high solubility of product 136 toward the ionic liquid. In contrast, in the
Aldol II reaction, as compared with the reaction in water, the product selectivity
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in ionic liquids are increased. This is because the hydrogenated product of 136 is
difficult to dissolve in water but is easy in ionic liquids.
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Scheme 3.17. Aldol Condensation Reaction

135

137

136

138

139

Synthesis of Isopropyl glycosides
In another study, trichloroacetamidate donors (TCA) were used in glycosylation
reactions in [bmIm][PF6] and [emIm][OTf] with monosaccharide derivatives.118
(Scheme 3.18).
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Scheme 3.18. Synthesis of Isopropyl Gycosides

140

141

Synthesis of Furan Diol
2-(D-glycero-1,2-dihydroxyethyl) furan 142 is a potential chiral building block used
as an intermediate in the organic synthesis of biologically significant
products.119,120 Monosaccharides are extremely acid-labile and under hydrolytic
conditions lead to furans. Thus, in 1966, the first transformation of D-glucal 106 to
optically active furan diol was reported, using H2O/HOAc at 170 0C. 121,122 RTILs
in this transformation were used as catalyst promoters with 10% InCl3.3H2O as
the catalyst and acetonitrile as the solvent at room temperature. (Scheme 3.19)
Scheme 3.19. Synthesis of Furan Diol.

106

142

68

3.3.4. The Synthesis of Pyranobenzopyran Using Ionic Liquids
The application of ionic liquids in a variety of reactions and their success in
obtaining the required product in good yields encouraged us to think about the
use of ionic liquids as solvent in the synthesis of pyranobenzopyrans. Three
different ionic liquids were used, 1-butyl-3-methylimidazolium tetrafluoroborate,
1-butyl-3-methylimidazolium hexafluorophosphate and 1-ethyl-3-methylimidazolium
ethylsulfate, to study the effect of the different anions and alkyl chain lengths on
the imidazolium ion in the yield of the products. The choice of imidazolium ionic
liquids was due to their reported physical properties and suitability for the
reactants. The ionic liquids based on the [bmim]+ have low melting points, for
example The [bmim]PF6 salt has a melting point of 58-60 0C while the [bmim]
BF4- and the [emim] EtSO3- salts have melting points of 15 and -20 0C,
respectively.102 These ionic liquids have low viscosities, are air and moisture stable
and are easily and cheaply synthesized. They can also dissolve a wide range of
organic and inorganic compounds which make them applicable in organic
synthesis. These properties have opened up the avenue of using them as
potential replacement solvents. At present, the most widely used

ionic liquids

are the species based on 1 –methylimidazole. Examples of this group of ionic
liquids are [bmim]PF6 and [bmim]BF4 which are widely used in synthesis. They
are neutral stoichiometric compounds and they are stable to both air and
moisture. Also, they are easily synthesized without great expense. They have low
densities, viscosities, and they are liquids below room temperature. 102-105 Two of
our ionic liquids were synthesized in lab 1-butyl-3-methylimidazolium
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tetrafluoroborate 144 (Scheme 3.20) and 1-butyl-3-methylimidazolium
hexafluorophosphate (Scheme 3.21), using known procedures from the
literature.123 The yields obtained for both of them were 92%.
Scheme 3.20. Synthesis of 1-Butyl-3-methylimidazolium Tetrafluoroborate

143

144

Scheme 3.21. Synthesis of 1-Butyl-3-methylimidazolium Hexafluorophosphate

145

146

Cycloaddition reactions were carried out using the previously described method,
in which the protected D-glucals were added to the o-hydroxybenzalimines in an
ionic liquid solvent (ILS) and catalyzed with scandium triflate at room
temperature. (Scheme 3.22).
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Scheme 3.22. Synthesis of Pyranobenzopyran Using Ionic Liquids.

108
OR = Acetyl, Silyl, Benzyl

89

109

ILS = 1-butyl-3-methylimidazolium tetrafluoroborate, 1-butyl-3-methylimidazolium

hexafluorophospate, 1-ethyl-3-methylimidazolium ethylsulfate

Tri-O-acetyl and tri-O-benzyl D-glucal were insoluble in the ionic liquids whereas
the tris-O-tert-butyldimethylsilylglucal give a very sticky mixture which was difficult
to stir. No reaction was observed to take please with this sugar nor was product
obtained. The reason for the failure of these reactions was likely the higher
polarity and viscosity of the ionic liquid. With this in mind, we decided to use
D-glucal due to its inherent polarity. (Scheme 3.23).
Scheme 3.23 Synthesis of Pyranobenzopyran Using D-glucal in Ionic Liquids
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R = Bn, Ac, TBDMS
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The D-glucal dissolved well in both 1-butyl-3-methylimidazolium tetrafluoroborate
and 1-ethyl-3-methylimidazolium ethylsulfate ionic liquids, as did all the other
components of the reaction, to give homogenous mixtures with a brown color.
Though the mixtures were stirred for 48 hours the TLC using mixture of
(4:1 hexane/EtOAC,) acetate) did not show the formation of any product., If the
reaction was stirred longer, decomposition of the imine to the aniline and ohydroxybenzaldehyde was observed. We concluded that our procedure was not
suitable for the conversion of D-glucal, and we decided to try another literature
procedure for the synthesis of pyranobenzopyrans.63 First, we stirred a mixture of
o-hydroxybenzaldehyde, triethyl orthoformate and Sc(OTf)3 for 20 min and then
added it to the solution of the D-glucal in ionic liquid (Scheme 3. 24). The
reaction was stirred for 72 h, and the reaction completion was monitored by thin
layer chromatography. Many spots were observed on the TLC. The two major
spots were isolated using column chromatography and were identified as
chromene derivative 147 and furan diol 142. The structures of those molecule and
all of the other products formed were determined from 1D and 2D, 1H and 13C
NMR experiments.
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Scheme 3.24. Addition Reactions of D-glucal and o-Hydroxybenzaldehydes

82

106

147

142

R = H, Cl, Br, OMe, NO2, OH, Me

The Proposed Mechanism of the Reaction
The reaction of 2-hydroxybenzaldehyde with triethyl orthoformate probably
proceeds through the intermediate formation of 148 and then the formation of
the oxa- diene 149, (step1). In the other hand the stirring of the D-glucal with
Sc(otf)3 in the ionic liquid lead to the formation of the D-glucal diene 150,
(step2). The addition of the sugar diene 150 that react as dienophile to the oxadiene in a [4+2] cycloaddition to generate the oxygen-containing six member ring
147, and furan diol as major by-product .
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Step1 Formation of Oxa Diene

82

148

149

Step2 Formation of the D-glucal Diene

106

150

Step 3 The Cycloaddition Reaction

149

150

147
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Reaction Optimization
In order to study the effect of substituent on the synthesis of
pyranobenzopyrans several salicylaldehyde derivatives 82a-82g
were reacted with glucal 106. Unfortunately most of the salicylaldehyde derivatives
have moderate to zero solubility in the ionic liquids which leads to a reduction of
the yield of the major products and an increase in the yield of by-products. The
yields for the products 147a-147d ranged from 36% to 79%. With all of the
soluble salicylaldehyde derivatives and glucal addition reactions, furan by-product
142 was also obtained (39-58%). Acetonitrile was added as co-solvent in the
reaction to improve the solubility of ionic liquid insoluble salicylaldehyde
derivatives such as 2-hydroxy-5-nitrobenzaldehyde, 2-hydroxy-5methylbenzaldehyde and 2,5-dihydroxybenzaldehyde. 2-Hydroxy-5-nitrobenzaldehyde
was completely dissolved in the mixture of the ionic liquid with acetonitrile,
whereas 2-hydroxy-5-methylbenzaldehyde and 2,5-dihydroxybenzaldehyde were
partially dissolved but no product was formed after stirring for 72 hours at room
temperature. Our success in the synthesis using ionic liquids encouraged us to
try different dienes, E-chalcone 153, was first prepared as the starting material
using the known literature procedure.124 (Scheme 3.25). A representative
experimental procedure for this involved a room temperature reaction between
benzaldehyde 151, acetophenone 152 and a saturated sodium hydroxide solution
in 95% ethanol.
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Scheme 3.25. Synthesis of E-Chalcone

151

152

153

Once the E-chalcone 153 was synthesized we added it to D- glucal 106 in ionic
liquid in the presence of scandium triflate (Scheme 3.26). The E-chalcone 153
was insoluble in the ionic liquid in both conditions, at room temperature, or
when it was heated to 80 0C.
Scheme 3.26. The Reaction Between D-glucal with E-Chalcone.

153

106

154

D-glucal 106 and 1-methoxy-3-trimethylsiloxy-1, 3-butadien 155 was also reacted in
ionic liquid solvent in the presence of Sc(OTf)3. The electron donating nature of
this diene is known to confer higher reactivity and orientational specificity in its
reaction with unsymmetrical dienophiles.125 We first conducted this reaction at
room temperature but it took a long time (72 hours) and a low yield (56%) was
76

obtained for the main product Then we heated the reaction to 80 0 C for 12
hours to optimize for the product. The resulting molecule, 2-5,8a-dihydroxy1(hydroxymethyl)-1, 4a, 5, 6, 7,8a-hexahydro-8H-isochromeneone 156 was obtained
in 76 % yield (Scheme 3.27). Upon our successes in this reaction we used the
microwave reactor to provide heat and shorten the reaction time, the reaction
mixture was heated for a range of time from 2 to 10 minutes at 80 0C R = Bn,
Ac, TBDMS had occurred.
Scheme 3.27 Reaction of Danishefsky’s Diene with D-Glucal

155

106

156

142

In general, we assumed the [4+2] cycloaddition reaction would take place
between the diene and the unsaturated carbons in D-glucal but the 1H NMR and
13C

NMR showed the glucal double bonds were still present around 6 ppm in

all the predicted structures. The tables below summarize the 1H and 13C data and
illustrate the assigned structures 147a-147d, 156. Then we believed that the
reaction occured via the initial formation of a sugar diene that reacts as a
dienophile where the other reactants in a [4+2] cycloaddition to generate the
oxygen-containing six-membered ring. The fact that D-glucal 106 could participate
as both the diene or as the dienophile in these ionic liquid mediated reactions
was evidenced by the formation of the glucal dimer 157 (Scheme 3.27). The
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formation of furan diol 142 can also be accounted for via an acid catalyzed
elimination such as that leading to intermediate 157 or a similar ring opened
analog.
Scheme 3.28. Dimerization of D-Glucal.
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157
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Table 3.4. 1-(hydroxymethyl)-1H,10H-pyrano[4,3-b]chromenee-10,10a(4aH)-diol (9a)
147a

Atom label

1H

Chemical Shift

13C

Chemical Shift

(ppm)

(ppm)

1

6.34

144.02

2

4.74

106.23

3

4.38

81.97

4

4.77

100.30

5

4.25

69.58

6, 6’

3.94-3.81

66.72

7

5.96

68.98

8

128.77

9

130.93

10

7.43

116.87

11

6.90

128.77

12

6.87

120.10

13

7.22

130.93
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Table 3.5. 12-chloro-1-(hydroxymethyl)-1H, 10H-pyrano[4,3-b]chromenee-10,10a(4aH)diol 147b

Atom label

1H

Chemical Shift

13C

Chemical Shift

(ppm)

(ppm)

1

6.35

143.11

2

4.47

105.34

3

4.42

81.04

4

97.72

5

4.29

68.60

6, 6’

3.91

55.8

7

5.93

68.06

8

11760

9

129.71

10

6.88

127.43

11

7.22

129.47

12
13

127.43
7.42

129.47
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Table 3.6.14-(hydroxymethyl)-12-methoxy-1H,10H- pyrano[4,3-b]chromenee-10,
10a(4aH)-diol 147c

Atom label

1H

Chemical Shift

13C

Chemical Shift

(ppm)

(ppm)

1

6.35

144.03

2

4.74

106.15

3

4.41

81.90

4

99.96

5

4.35

69.53

6, 6’

3.90-3.80

66.72

7

5.90

68.93

8

124.88

9

153.78

10

6.80

116.49

11

6.80

117.64

12

113.71

13

6.99

14

3.72

149.50
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Table 3.7. 12-bromo-1-(hydroxymethyl)-6 methoxy-1H, 10-H-pyrano[4,3-b]c10, 10a
(4aH)-diol 147d

Atom label

1H

Chemical Shift
(ppm)

13C

Chemical Shift
(ppm)

1

6.38

2

4,76

110.94

3

4.25

81.89

4

97.38

5

3.84

69.62

6, 6’

3.84

66.73

7

5.99

68.95

8

126.51

9

144.03

10

144.03

11

7.25

12

115.65
149.31

13

7.11

122.72

14

3.89

56.86
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Table 3.8. 1a-dihydroxy-7-(hydroxymethyl)-1, 4 a, 5, 6, 7, 8a-hexahydro-1Hisochromene-1-one 156

Atom label

1H Chemical Shift

13C Chemical Shift

(ppm)

(ppm)

1

6.29

144.16

2

4.75

103.83

3

4.39

80.47

4

98.95

5

4.20

68.05

6, 6’

3.60

66.66

7

68.34

8, 8’

2.13

31.21

9

2.81

48.28

10

5.06

204.1
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Table 3.9. D-Glucal Dimer 157

Atom label

1H Chemical Shift

13C Chemical Shift

(ppm)

(ppm)

1

6.28

143.36

1,

3.36

79.20

2

4.56

104.70

2,

5.06

104.90

3

3.10

69.60

3,

4.83

143.25

4

68.92

4,

79.44

5

3.60

79.94

5,

3.60

79.70

6a, 6b

3.98, 3.70

68.85

6,a, 6,b

3.57

60.84

84

3.3.4. Summary
In this research, we examined three imidazolium-based ionic liquids as solvents
in cycloaddition reactions. The choice of these ionic liquids is based on their
features such as ease of modifications, stability under acidic conditions. 126
1-butyl-3-methylimidazolium tetrafluoroborate (Table 3.10) and 1-ethyl-3methylimidazolium ethylsulfate ionic liquid (Table 3.11),
readily solubilized D- glucal 106, o-hydroxybenzaldehyde and its derivatives, triethyl
orthoformate and Sc(OTf)3 whereas the ionic liquid 1-butyl-3-methylimidazolium
hexafluorophospate was very poor at solubilizing those reagents. The difference in
these three RTILs and their solubilizing ability for D-glucal 106 is a good example
of the tunable properties of ionic liquids. In general, we observed the yields from
1-ethyl-3-methylimidazolium ethylsulfate were much better due to the higher
solubility of D-glucal than in the other solvents. In this medium, the difference in
the viscosity of the IL determines its reaction rates with D-glucal. The reactant
particles diffuse faster in less viscous solvents and can collide at a higher
frequency per unit time. Thus the reaction rates decrease rapidly with the
increase of solvent viscosity. The viscosity of 1-ethyl-3-methylimidazolium
ethylsulfate is 122 mpa where the viscosity for 1-butyl-3-methylimidazolium
tetrafluroborate 135 mpa.127
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Table 3.10. The Result Obtained Using the 1-butyl-3-methylimidazolium
Tetrafluoroborate Ionic Liquid Solvent
Entry

Diene

Product

% Yield

1-

51

2-

57

3-

53

By-product

% Yield

29

“

41

“

32

4-

36

“

53

5-

61

“

23

6-

32

“

53
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Table 3.11. Cycloaddition Reactions with 1-ethyl-3-methylimidazolium ethylsulfate Ionic
Liquid
Entry

Diene

Product

% Yield

1-

73

2-

78

“

“

58

5-

76

6-

32

% Yield

22

72

3-

4-

By-product

“

“

“

18

21

37

17

53
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Summary
The reaction of carbohydrates in organic solvents typically requires protection of
the hydroxyl groups as non-polar-moieties to enhance their solubility. Later, a
subsequent deprotection step is carried out to remove the protecting groups. In
this part of our research we have been able to synthesize a series of
pyranobenzopyrans 147a-147d in modest yields. Furan diol 142 was isolated as
the major byproduct from these reactions. Lewis acid-catalyzed cycloaddition
reactions of D-glucal 106 with different dienes were carried out in room
temperature ionic liquids. The products obtained from these reactions are shown in
Table 3.10.
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Chapter 4
Conclusion

4.1. Summary
The goal of this project was to develop a method for the synthesis of
pyranobenzopyrans and carbohydrate-fused heterocyclic compounds. This was
accomplished via a [4+2] cycloaddition reaction to generate the oxygencontaining six-membered ring by the addition of the imine 64;
o-hydroxybenzaldimine and its derivatives to glucals in organic solvent under
catalysis by scandium triflate. The conventional method and microwave reactor
method were initially used to achieve this goal, but no reaction was observed in
both cases The failure of this reaction under these cases may due to the sugar
protecting groups such as acetyl, benzyl and t-butyldimethylsilyl that made steric
hindrance and inhibited the reaction. Then new methodology was developed and
an ionic liquid was used as solvent to dissolve the D-glucal and the other
reactants. A series of pyranobenzopyrans have been prepared via Lewis Acid
catalyzed cycloaddition reactions of D-glucal and o-hydroxybenzaldehyde and its
derivatives in room temperature imidazolium ion-based ionic liquid solvents.
Different o-hydroxybenzaldehyde derivatives 82a-82g were tested to study the
effect of the substituents on the rate of the reaction. Four products were
obtained 147a-147d in poor to moderate yields. Because 2-hydroxy-5nitrobenzaldehyde, 2-hydroxy-5-methylbenzaldehyde and 2,5-dihydroxybenzaldehyde
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were insoluble in the ionic liquids, no product was obtained from their reaction
with D-glucal. Danishefsky’s Diene, and 1-methoxy-3-trimethylsiloxy-1, 3-butadiene
155, were also reacted in ionic liquids and the product 2-5,8a-dihydroxy1(hydroxymethyl)-1,4a, 5, 6, 7,8a-hexahydro-8H-isochromeneone 156 was obtained
in moderate yield. In these reactions, the glycal itself was found to serve as a
diene with another molecule of glycal as the dienophile to form an interesting
sugar dimer.
In conclusion, we successfully synthesized pyranbenzopyran derivatives and their
structures were confirmed by using 1-D 1H and 2-D 1H and

13C

NMR

4.2. Experimental Section
General methods: Proton nuclear magnetic resonance (1H NMR) spectra were
recorded on a Varian Inova (500 MHz) spectrometer. NMR samples were
dissolved in d6 -acetone, d1-chloroform or d6-DMSO and chemical shifts were
reported in ppm relative to the residual non-deuterated solvent (acetone methyl
group at 2.05 ppm) or to the methyl protons on tetramethylsilane (TMS, 0.00
ppm). 1H NMR data are reported as follows: chemical shift, integration, multiplicity
(s = singlet; d = doublet; dd = doublet of doublet; ddd = doublet of doublet of
doublets; m = multiplet), coupling constant, and assignment. 13C NMR were recorded
on the same instrument (125 MHz). The 13C chemical shift were reported relative
to the references at 29.84, 77.23 and 39.51 ppm, respectively. All the NMR
experiments were run at room temperature (25 0C) and assignments were done
by using gCOSY and gHMQC. The mass spectra were obtained at the University of
Illinois (Champaign-Urbana). Both the higher resolution and the low resolution
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mass spectra were obtained by ESI (electron spray ionization). Melting points (mp)
were measured on a Mel-Temp melting point apparatus (Laboratory Devices, Inc.,
USA). The optical rotations were recorded on automatic polarimeter (Rudolph
Instruments, New Jersey USA). Reactions were monitored by thin-layer
chromatography (TLC) on 0.25 mm silica gel coated aluminum sheets 60 F254
(Analtech). Silica gel (particle size 40–63 Å, 230–400 mesh) (Silicycle) was used for
flash column chromatography. Preparative thin-layer chromatographic separations
were carried out on 2000 mm silica gel coated glass plates 60 F254 (Analtech).
All the reactions were carried out in oven-dried glassware under nitrogen.
D-glucal was prepared from commercially-available 3, 4, 6-tri-O-acetyl-D-glucal
(Aldrich Chemical Co.). The ionic liquids were prepared using 1-methylimidazole,
1-bromobutane, sodium tetrafluoroborate or sodium hexafluorophospate at 80 0C
All the starting materials and reagents were obtained from Alfa Aesar and Sigma
Aldrich Chemical Companies. 4.2.1. Representative Experimental Procedures
3.2.1. 1-(hydroxymethyl)-1H,10H-pyrano[4,3-b]chromenee-10, 10a(4aH)-diol (147a).
A mixture of o-hydroxybenzaldehyde 8a (287 µL, 2.7 mmol), triethyl orthoformate
(558 µL, 2.7 mmol) and scandium triflate (66 mg) was stirred in 5 mL of 1-butyl-3methyimidazolium tetrafluoroborate or 1-ethyl-3-methylimidazolium ethylsulfate for
20 min then (400 mg, 2.7 mmol) D-glucal 106 was added to the mixture. The
resulting mixture was stirred at ambient temperature until complete conversion
was indicated by TLC. The reaction mixture was quenched with water (20 mL)
and extracted with ethyl acetate (3 x 10 mL); the combined organic extracts were
dried over anhydrous sodium sulfate, and concentrated in vacuo. The crude
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product was purified by column chromatography using mixture of
(98:2 CHCl3/CH3OH) followed by repurification on a 2000 µm silica gel thin layer
chromatography plate. All subsequent reported yields were from reactions
conducted in 1-butyl-3-methyimidazolium tetrafluoroborate. NMR assignments refer
to the following ring positions:

The final product 147a was a white powder (0.376 g, 1.38 mmol, 51% ): mp 118
0C:

Rf (98:2 CHCl3 /CH3OH): 0.36; [α]D 21`+ 8.6 (c 0.75, CHCl3); 1H NMR (500 MHz,

d6 acetone) δ 7.22 (m, 2H, H-13, H-10, Ar), 7.09 (m, 2H, H-11,H-14 Ar), 6.34 (dd, 1H,
J1,2 = 6.0, J1,3= 1.5 Hz, H-1), 5.96 (s, 1H, H-7), 4.74 (dd, 1H, J2,1= 6.0 Hz, J2,3= 1.5
Hz, H-2), 4.38 (ddd, 1H, J = 6.5 Hz, J3,2 = 2.0 Hz, J3,1=1.5 Hz, H-3 ), 4.25 (dd, 1H,
J5,6 = 10.0 Hz, J5, 6’= 5.0Hz, H-5), 3.94-3.81 (m, 2H, H-6, H-6’); 13C NMR (125 MHz,
d6 acetone) δ 144.02 (C-1), 130.93 (2C) (C-13, C-9), 128.77 (2C) (C-11, C-8),
120.10 (C-12), 116.87 (C-10), 106.23 (C-2), 100.30 (C-4), 81.97 (C-3), 69.58 (C-5),
68.98 ( C-7), 66.72 ( C-6 ). HRMS (ESI): Calcd.for C13H14O5 for (M+Na)+ 273.0741.
Found 273.0739. Compound 142 (0.100 g, 0.78 mmol, 29%) was also isolated as a
colorless oil: Rf (98:2 CHCl3/CH3OH): 0.48. The 1H NMR (500 MHz, CDCl3) was in
good agreement with previously reported data for this compound. 13C NMR (125
MHz, d6-acetone) 153.59 (C1), 141. 55 (C4), 110.18 (C2), 106. 42 (C3), 63.06 (C1’),
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42.43 (C2’); HRMS (ESI): Calcd for C6H8O3 for (M + H)+ 128.04735. Found
128.04773.
3.2.2. 8-chloro-1-(hydroxymethyl)-1H, 10H-pyrano[4,3-b]chromenee-10,10a(4aH)diol (147b).
The title compound was obtained as white powder (0.473 g, 1.5 mmol, 57%) : mp
71 0C: Rf (98:2 CHCl3 /CH3OH): 0.38; [α]D22 - 9.7(c 0.75, CHCl 3); 1H NMR (500 MHz,
d6 acetone) δ 7.42 (d, 1H, J1 3,11 = 1.5 Hz, H-13, Ar), 7.22 (dd, 1H, J 11,10 =6.5 Hz,
J11,13 =2.5 Hz, H-11, Ar), 6.88 (d, 1H, J10,11 =9.0 Hz, H-10, Ar), 6.35 (d, 1H, J1,2 =
6.0 Hz, H-1), 5.93 (s, 1H, H-7), 4.74 (dd, 1H, J2,1= 6.0 Hz, J2,3= 1.5 Hz, H-2), 4.42
(brs, 2H, H-3, OH), 4.29 (dd, 1H, J5,6 =10.0 Hz, J5,6’= 5.0 Hz, H-5), 3.91 (m, 2H, H-6,
H-6’); 13C NMR (125 MHz, d6 acetone) δ 154.47 (C-12), 143.11 (C-1), 129.71 (2C) (C13, C-9), 127.43 (2C) (C-11, C-12), 105.34 (C-2), 97.72 (C-4), 81.04 (C-3), 68.60 (C5), 68.06 (C-7), 55.80 (C-6); HRMS (ESI): Calcd. for C13H14O5 for (M+Na)+
307.0352. Found 307.0349. Elution also afforded 142 (0.142 g, 1.11 mmol, 41%).
3.2.3. 1-(hydroxymethyl)-8-methoxy-1H, 10H- pyrano[4,3-b]chromenee-10,
10a(4aH)-diol (147c).
The title compound was obtained as white powder (0.434 g, 1.43 mmol, 53%) : mp
87 0C: Rf (98:2 CHCl3 /CH3OH): 0.40; [α]D21+ 8.9 (c 0.75, CHCl3); 1H NMR (d6 acetone)
δ 7.66 (brs, 1H, OH), 6.99 (d,1H, J13,11 = 2.0 Hz, H-13, Ar,), 6.80 (m, 2H, H-10,11, Ar),
6.35 (d, 1H, J1,2 = 4.5 Hz, H-1), 5.90 (s, 1H, H-7), 4.74 (dd, 1H, J2,1 = 5.0 Hz, J2,3 =
1.5 Hz, H-2), 4.45 (brs, 1H , OH), 4.41 (dd, 1H, J3,2 = 6.0 Hz, J3,1 = 2.0 Hz, H-3), 4.35
(dd, 1H, J5,6 = 10.0, J5,6’ = 5 Hz, H-5), 3.90- 3.80 (m, 2H, H-6, H-6’), 3.72 (s, 3H, H-
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14); 13C NMR (d6 acetone) δ 153.78 (C-9), 149.50 (C-13), 144.03, (C-1) 124.88 (C-8),
117.64 (C-11), 116.49 (C-10), 113.71 (C-13), 106.15 (C-2), 99.96 (C-4), 81.90 (C-3),
69.53 (C-5), 68.93 (C-7), 66.72 (C-6), 55.98 (C-14); HRMS (ESI): Calcd. for C14H16O6
for (M+Na)+ 303.0839. Found 303.0845. Furan diol 142 was also obtained (0.110 g,
0.87 mmol, 32%).
3.2.4. 8-bromo-1-(hydroxymethyl)-6 methoxy-1H, 10H-pyrano[4,3-b]c10, 10a
(4aH)-diol 147d The title product was obtained as white powder (0.349 g, 0.97
mmol, 36 %); mp 92 0C; Rf (98:2 CHCl3 /CH3OH): 0.42; [α]D22+ 12.4 (c 0.75, CHCl3);
1H NMR (d6 acetone) δ 7.25 (d, 1H, J11,13 = 2.5 Hz, H-11 Ar), 7.11 (d, 1H, J13,11 =
2.5 Hz, H-13 Ar), 6.38 (dd, 1H, J1,2 = 6.0 Hz, J1,3 =1.5 Hz, H-1), 5.99 (s, 1H, H-7),
4.76 (dd, J2,1 = 6.0 Hz, J2,3 = 1.2 Hz, H-2), 4.25 (dd, 1H, J3,2 = 1.5 Hz, J3,1 = 1.2 Hz,
H-3), 3.89 (s, 3H, H-14), 3.84 (m, 3H, H-5, 6, 6’); 13C NMR (d6 acetone) δ 149.31 (C12), 144.48 (C-1), 144.03 (2C)(C-9, C-10), 126.51 (C-8), 122.72 (C-13), 115.65 (C11), 110.94 (C-12), 106.22 (C-2), 97.38 (C-4), 81.89 (C-3), 69.62 (C-5) 68.95 (C-7),
66.73 (C-6), 56.86 (C-14). HRMS (ESI): Calcd for C14H15O6 for (M+H)+ 359.0115.
Found 359.0130. Compound 142 was also isolated (0.183 g, 1.43 mmol, 53%).
3.3. 8a-dihydroxy-1-(hydroxymethyl)-1, 4 a, 5, 6, 7, 8a-hexahydro-8H-isochromene8-one (156).
A mixture of D-glucal 106 (400 mg, 2.7 mmol), 1-methoxy-3-trimethylsiloxy-1 3butadiene 155 (517 mg 3.0 mmol) and scandium triflate (66 mg) in 1-butyl-3ethyimidazolium tetrafluoroborate (5 mL) was stirred overnight at 80 0C. After
completion of the reaction, as indicated by TLC using mixture of 98:2
(CHCl3/CH3OH), the reaction mixture was quenched by addition of water (20 mL)
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and extracted with ethyl acetate (3 x 10 mL). The combined organic layers were
dried over anhydrous sodium sulfate, and the resulting product was purified by
column chromatography using mixture of 98:2 (CHCl3/CH3OH) followed by a
second purification on a 2000 µm thin layer SiO2 chromatography plate and the
pure product was concentrated in vacuo. The final product 156 was white powder
(0.354 g, 1.6 mmol, 61%) : mp 95 0C; Rf (98:2 CH3OH/CHCl3): 0.32; [α] D21 + 36.2 (c
0.80 ,CHCl3); 1H NMR (500 MHz,CDCl3) δ 6.15 (dd,1H, J1,2 = 6.5, J1,3 = 2.0 Hz, H-1),
4.92 (dd, 1H, OH), 4.60 (dd,1H, J2,1 = 6.0, J2,3 = 2.5 Hz, H-2), 4.24 (ddd, 1H, J3,7=
5.5, J3,2= 2.5 Hz, J3, 1 -=1.2 Hz, H-3), 4.05 (dd, 1H, J5,6 =10.0, J5, 6a = 5.5 Hz, H-5),
3.60 (m, 1H, H-7), 3.50 (m, 2H, H-6, H-6a), 2.67 (dd, 2H, J= 5.00 Hz, H-9, H-9a ), 2.13
(m, 2H, H-8, H-8a). 13C NMR (125 MHz, CDCl3) 204.1 (C-10), 144.16 (C-1), 103.83
(C-2), 98.95 (C-4), 80.47 (C-3), 68.34 (C-7), 68.05 (C-5), 66.66 (C-6), 48.28 (C-9),
31.21 (C-8). HRMS (ESI): Calcd for C10H14O5 for (M+H+) 215.0917. Found
215.0919; Prior elution also gave 142 (0.08 g, 0.62 mmol, 23%).
3.4. D-Glucal Dimer (157).
A mixture of D-glucal 106 (400 mg, 2.7 mmol) and scandium triflate (66 mg) was
stirred in of 1-butyl-3-methyimidazolium tetrafluoroborate (5 mL) overnight at 80 0C.
The crude product was purified by column chromatography (92:8 CHCl3/CH3OH)
to afford product 157 as a white solid (0.221 g, 0.86 mmol, 32 %) : mp 78 0C: Rf
(92:8 CHCl3 /CH3OH): 0.29; 1H NMR (d6 DMSO) δ 6.28 (dd, 1H, J1,2 = 6.0 Hz,
J1,3=1.5 Hz, H-1), 5.06 (brd, 1H, J2’, 3’= 4.5 Hz, H-2’), 4.83 (brd, 1H, J3’, 2’ = 4.5 Hz,
H-3’), 4.56 (m, 2H, H-2, H-4’), 3.98 (brs, 1H, H-6a), 3.70 (brs, 1H, H-6b), 3.57 (d, 2H,
J6’a,6’b = 10.5 Hz, H-6’a, H-6’b), 3.36 (brs, 1H, H-5), 3.10 (m, 1H, H-5’); 13C NMR
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(CDCl3) δ = 143.36 (C-1), 143.25 (C-3’), 104.90 (2C) (C-2, C-2’), 79.94 (C-5), 79.70 (C5’), 79.44 (C-4’), 79.20 (C-1’) 69.60 (C-3), 68.92 (C-4), 68.85 (C-6), 60.84 (C-6’)
LRMS (ES+): Calcd C12H16O6 for (M+Na)+ 256.08. Found 256.09. Compound 142
was also obtained (0.183 g, 1.43 mmol, 53%).
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